Moderna raises $110mm in second financing round

Messenger RNA company Moderna Therapeutics Inc. raised $110mm through what appears to be the company's Series B round. The financing came from 39 undisclosed private investors, a large syndicate that EBI assumes includes the company's only published investor--Flagship Ventures. Moderna has now raked in $415mm in cash in just one year: a $40mm first round in December 2012; $240mm up front from AstraZeneca as part of a 40-project licensing deal signed in March; a $25mm grant from the Defense Advanced Research Projects Agency in October; and the current $110mm financing.